Someone should call these people and see if they'll say anything.
Proequities, Inc. closes position in US8677814035 / Sunshine Biopharma Inc
UBS Group AG reports 99.96% decrease in ownership of US8677814035 / Sunshine Biopharma Inc
Jane Street Group, Llc closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Jane Street Group, Llc
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Armistice Capital, Llc closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Armistice Capital, Llc
Manager Steven Boyd
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Hudson Bay Capital Management LP closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Hudson Bay Capital Management LP
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Hudson Bay Capital Management LP closes position in US8677814035 / Sunshine Biopharma Inc
2022-08-12 - Hudson Bay Capital Management LP has filed a 13F-HR form disclosing ownership of 0 shares of Sunshine Biopharma Inc (US:US8677814035) with total holdings valued at $0 USD as of 2022-06-30. Hudson Bay Capital Management LP had filed a previous 13F-HR on 2022-05-16 disclosing 315,000 shares of Sunshine Biopharma Inc at a value of $720,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.
Empery Asset Management, LP closes position in US8677814035 / Sunshine Biopharma Inc
Security US8677814035 / Sunshine Biopharma Inc
Institution Empery Asset Management, LP
Manager Ryan Matthew Lane and Martin David Hoe
Latest Disclosed Ownership 0 shares
Latest Disclosed Value $ 0
Related SBFM / Sunshine Biopharma, Inc.
Empery Asset Management, LP closes position in US8677814035 / Sunshine Biopharma Inc
2022-08-12 - Empery Asset Management, LP has filed a 13F-HR form disclosing ownership of 0 shares of Sunshine Biopharma Inc (US:US8677814035) with total holdings valued at $0 USD as of 2022-06-30. Empery Asset Management, LP had filed a previous 13F-HR on 2022-05-16 disclosing 450,450 shares of Sunshine Biopharma Inc at a value of $1,104,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.
